Patent Assignment
Reel/Frame 027278/0787
Security Agreement
Recorded: 2011-11-23
Received: 2011-11-23
Pages: 11
Assignor
KADMON CORPORATION, LLC
Executed: 2011-10-31
Assignee
CORTLAND CAPITAL MARKET SERVICES LLC, AS ADMINISTRATIVE AGENT
225 W. WASHINGTON STREET, SUITE 1450, CHICAGO, IL, 60606, UNITED STATES
Covered Properties
(24)
Use of the Combination of PHY906 and a Tyrosine Kinase Inhibitor as a Cancer Treatment Regimen
Application:
12/997,513 →
INHIBITORS OF mTOR KINASE AS ANTI-VIRAL AGENTS
Application:
61/436,970 →
Nucleoside Triphosphate Derivative, Nucleic Acid Probe, Multilabeled Nucleic Acid Probe, Method for Production of Multilabeled Nucleic Acid Probe, and Method for Detection of Target Nucleic Acid
Application:
13/003,380 →
Use of PHY906 as Treatment for Inflammatory Bowel Disease and/or Irritable Bowel Syndrome
Application:
12/739,591 →
Receptor-Type Kinase Modulator and Methods of Treating Polycystic Kidney Disease
Application:
61/377,211 →
Herbal Composition PHY906 and Its Use in Chemotherapy
Application:
12/527,302 →
Pharmacokinetically Improved Compounds
Application:
12/570,153 →
Receptor-Type Kinase Modulators and Methods of Use
Application:
12/455,867 →
Methods of Inhibiting Receptor Tyrosine Kinases with an Extracellular Antagonist and an Intracellular Antagonist
Application:
12/361,350 →
Methods of Making Pharmacokinetically Improved Compounds Comprising Functional Residues or Groups and Pharmaceutical Compositions Comprising Said Compounds
Application:
11/884,811 →
Treatment of Viral Infections by Modulation of Host Cell Metabolic Pathways
Application:
12/156,517 →
Pharmacokinetically Improved Compounds
Application:
11/887,218 →
Treatment of Viral Infections by Modulation of Host Cell Metabolic Pathways
Application:
61/033,243 →
Treatment of viral infections by modulation of host cell metabolic pathways
Application:
60/932,769 →
Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist
Application:
10/560,209 →
Inhibitors of Microsomal Triglyceride Transfer Protein and Apo-B Secretion
Application:
11/407,500 →
Receptor-Type Kinase Modulators and Methods of Use
Application:
10/522,004 →
Herbal Composition PHY906 and Its Use in Chemotherapy
Application:
11/100,433 →
Use of Ribofuranose Derivatives Against Inflammatory Bowel Diseases
Application:
10/618,148 →
Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
Application:
60/477,796 →
Herbal Composition PHY906 and Its Use in Chemotheraphy
Application:
10/220,876 →
Nucleoside Compounds and Uses Thereof
Application:
10/318,476 →
Nucleoside Analogs with Carboxamidine Modified Monocyclic Base
Application:
10/227,235 →
Tirazole Nucleoside Analogs and Methods for Using Same
Application:
10/095,665 →